BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 202653)

  • 1. Identification of lipids associated with the ability of tumor cells to resist humoral immune attack.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Feb; 120(2):472-80. PubMed ID: 202653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between the ability of tumor cells to resist humoral immune attack and their ability to synthesize lipid.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Feb; 120(2):463-71. PubMed ID: 202652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma membrane and intracellular lipid synthesis in tumor cells rendered sensitive to humoral immune killing after treatment with metabolic inhibitors.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1979 Dec; 63(6):1475-83. PubMed ID: 292816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.
    Schlager SI; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1978 Sep; 61(3):931-4. PubMed ID: 278869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1980 Apr; 64(4):943-50. PubMed ID: 6988626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.
    Schlager SI; Boyle MD; Ohanian SH; Borsos T
    Cancer Res; 1977 May; 37(5):1432-7. PubMed ID: 192450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of tumor cell susceptibility to humoral immune killing through chemical and physical manipulation of cellular lipid and fatty acid composition.
    Schlager SI; Ohanian SH
    J Immunol; 1980 Sep; 125(3):1196-200. PubMed ID: 7410835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell lipid composition and sensitivity to humoral immune killing. I. Modification of cellular lipid and fatty acid content by metabolic inhibitors and hormones.
    Schlager SI; Ohanian SH
    J Immunol; 1980 Feb; 124(2):626-34. PubMed ID: 6243329
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of ethanol on glycerolipid and fatty acid metabolism in Hep G2 human-hepatoma cells.
    Angeletti C; de Alaniz MJ
    Acta Physiol Pharmacol Ther Latinoam; 1996; 46(2):57-69. PubMed ID: 8998370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of the synthesis and release of lipids in tumor cells under attack by antibody and C.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Mar; 120(3):895-901. PubMed ID: 632591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between lipid synthesis in tumor cells and their sensitivity to humoral immune attack.
    Schlager SI; Ohanian SH
    Science; 1977 Aug; 197(4305):773-6. PubMed ID: 196331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific 125I-iodination of cell surface lipids: plasma membrane alterations induced during humoral immune attack.
    Schlager SI
    J Immunol; 1979 Nov; 123(5):2108-13. PubMed ID: 489973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical and chemical composition of subcellular fractions from tumor cells treated with metabolic inhibitors or hormones.
    Schlager SI; Ohanian SH
    Cancer Res; 1979 Apr; 39(4):1369-76. PubMed ID: 421220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered lipid metabolism in human platelets after primary aggregation.
    Deykin D
    J Clin Invest; 1973 Feb; 52(2):483-92. PubMed ID: 4683885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for fatty acid composition of complex cellular lipids in the susceptibility of tumor cells to humoral immune killing.
    Schlager SI; Ohanian SH
    J Immunol; 1979 Jul; 123(1):146-52. PubMed ID: 448144
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics of hormone-induced tumor cell resistance to killing by antibody and complement.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1977 Mar; 37(3):765-70. PubMed ID: 189914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of lipids synthesized and released by tumor cells under attack by antibody and complement.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 May; 120(5):1644-50. PubMed ID: 659869
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2.
    Polo MP; de Bravo MG
    Biochem Cell Biol; 2006 Feb; 84(1):102-11. PubMed ID: 16462894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid and glycolipid metabolism of cultured astrocytes: a time course study.
    Yim SH; Monsma S; Hertz L; Szuchet S
    J Neurosci Res; 1986; 15(1):29-37. PubMed ID: 3007768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.